These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 6234351)

  • 21. Anti-CD4 monoclonal antibody-induced tolerance to MHC-incompatible cardiac allografts maintained by CD4+ suppressor T cells that are not dependent upon IL-4.
    Hall BM; Fava L; Chen J; Plain KM; Boyd RA; Spicer ST; Berger MF
    J Immunol; 1998 Nov; 161(10):5147-56. PubMed ID: 9820484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-TNF-alpha treatment down-regulates the expression of fibronectin and decreases cellular infiltration of cardiac allografts in rats.
    Coito AJ; Binder J; Brown LF; de Sousa M; Van de Water L; Kupiec-Weglinski JW
    J Immunol; 1995 Mar; 154(6):2949-58. PubMed ID: 7876561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of antibody in rat renal allograft rejection. II. Failure to enhance renal allografts by sensitization to donor class I antigens presented by donor strain erythrocytes.
    Majoor GD; Van Breda Vriesman PJ
    Transplantation; 1983 Feb; 35(2):121-6. PubMed ID: 6338632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune responses to organ allografts. III. Marked decrease in medullary thymocytes and splenic T lymphocytes after cyclosporin A treatment.
    Baldwin WM; Hutchinson IF; Meijer CJ; Tilney NL
    Transplantation; 1981 Feb; 31(2):117-20. PubMed ID: 7020171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adoptive transfusion of ex vivo donor alloantigen-stimulated CD4(+)CD25(+) regulatory T cells ameliorates rejection of DA-to-Lewis rat liver transplantation.
    Pu LY; Wang XH; Zhang F; Li XC; Yao AH; Yu Y; Lv L; Li GQ
    Surgery; 2007 Jul; 142(1):67-73. PubMed ID: 17630002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene transfer of soluble interleukin-17 receptor prolongs cardiac allograft survival in a rat model.
    Li J; Simeoni E; Fleury S; Dudler J; Fiorini E; Kappenberger L; von Segesser LK; Vassalli G
    Eur J Cardiothorac Surg; 2006 May; 29(5):779-83. PubMed ID: 16520057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allogeneic heart transplantation activates alloreactive NK cells.
    Petersson E; Ostraat O; Ekberg H; Hansson J; Simanaitis M; Brodin T; Dohlsten M; Hedlund G
    Cell Immunol; 1997 Jan; 175(1):25-32. PubMed ID: 9015185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunocytologic analysis of cells obtained from bronchoalveolar lavage in a model of rat lung allograft rejection.
    Kondo T; Wu GD; Saito R; Marchevsky AM; Prehn J; Matloff JM; Waters PF; Jordan SC
    J Surg Res; 1993 Oct; 55(4):351-6. PubMed ID: 8412122
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of TDTH and Tc populations in organ graft rejection. I. Functional analysis of graft-infiltrating T cells.
    Stepkowski SM; Duncan WR
    Transplantation; 1986 Oct; 42(4):406-12. PubMed ID: 3532452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Host resistance to cyclosporine induced syngeneic graft-versus-host disease. Requirement for two distinct lymphocyte subsets.
    Fischer AC; Laulis MK; Horwitz L; Beschorner WE; Hess A
    J Immunol; 1989 Aug; 143(3):827-32. PubMed ID: 2526175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of suppressor lymphocytes during acute rejection of rat cardiac allografts and preservation of suppression by anti-IL-2-receptor monoclonal antibody.
    Schneider TM; Kupiec-Weglinski JW; Towpik E; Padberg W; Araneda D; Diamantstein T; Strom TB; Tilney NL
    Transplantation; 1986 Aug; 42(2):191-6. PubMed ID: 2943063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppressor cells and intrathymic inoculation of donor alloantigens in cardiac transplantation.
    Shen Z; Mohiuddin M; DiSesa VJ
    Ann Thorac Surg; 1995 Dec; 60(6):1683-5. PubMed ID: 8787463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro growth of murine T cells. VI. Accelerated skin graft rejection caused by adoptively transferred cells expanded in T cell growth factor.
    Rosenstein M; Eberlein T; Kemeny MM; Sugarbaker PH; Rosenberg SA
    J Immunol; 1981 Aug; 127(2):566-71. PubMed ID: 7019327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analytical and functional studies on the T cells of untreated and immunologically tolerant diabetes-prone BB rats.
    Naji A; Silvers WK; Kimura H; Bellgrau D; Markmann JF; Barker CF
    J Immunol; 1983 May; 130(5):2168-72. PubMed ID: 6220083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of cyclosporine-induced autoreactive T lymphocytes in solid organ allograft survival and chronic rejection.
    Zhang H; Horwitz L; Ruvolo P; Colombani P; Hess AD
    Transplantation; 1995 Jul; 60(2):115-22. PubMed ID: 7624952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The expression of extracellular matrix proteins during accelerated rejection of cardiac allografts in sensitized rats.
    Coito AJ; Binder J; de Sousa M; Kupiec-Weglinski JW
    Transplantation; 1994 Feb; 57(4):599-605. PubMed ID: 8116048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclosporine therapy of rat heart allograft recipients and release of interleukins (IL 1, IL 2, IL 3): a role for IL 3 in graft tolerance?
    Abbud-Filho M; Kupiec-Weglinski JW; Araujo JL; Heidecke CD; Tilney NL; Strom TB
    J Immunol; 1984 Nov; 133(5):2582-6. PubMed ID: 6237152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T cell subsets in allograft rejection. In situ characterization of T cell subsets in human skin allografts by the use of monoclonal antibodies.
    Bhan AK; Mihm MC; Dvorak HF
    J Immunol; 1982 Oct; 129(4):1578-83. PubMed ID: 6213716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IL-2 and IL-4 double knockout mice reject islet allografts: a role for novel T cell growth factors in allograft rejection.
    Li XC; Roy-Chaudhury P; Hancock WW; Manfro R; Zand MS; Li Y; Zheng XX; Nickerson PW; Steiger J; Malek TR; Strom TB
    J Immunol; 1998 Jul; 161(2):890-6. PubMed ID: 9670967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD4 mAb therapy modulates alloantibody production and intracardiac graft deposition in association with selective inhibition of Th1 lymphokines.
    Kupiec-Weglinski JW; Wasowska B; Papp I; Schmidbauer G; Sayegh MH; Baldwin WM; Wieder KJ; Hancock WW
    J Immunol; 1993 Nov; 151(9):5053-61. PubMed ID: 8409456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.